Gilbert Wagener
Technik-/Wissenschafts-/F&E-Leiter bei PHARNEXT SCA
Aktive Positionen von Gilbert Wagener
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| PHARNEXT SCA | Technik-/Wissenschafts-/F&E-Leiter | 15.06.2023 | - |
Karriereverlauf von Gilbert Wagener
Ehemalige bekannte Positionen von Gilbert Wagener
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Ixaka Ltd.
 Ixaka Ltd. BiotechnologyHealth Technology Ixaka Ltd. engages in the development of advanced cell-based therapeutics for the treatment of critical limb ischemia. The company was founded by Gaby Salem and Vicente Saez Gonzalez in 2015 and is headquartered in London, the United Kingdom. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Cell2B - Advanced Therapeutics SA
 Cell2B - Advanced Therapeutics SA BiotechnologyHealth Technology Cell2B - Advanced Therapeutics SA engages in the development of stem cell therapies for immune and inflammatory diseases. Its pipeline consists of cord blood unit expansion and anti-rejection medications. The company was founded by Daniela Couto, David Braga Malta, Francisco dos Santos, and Pedro Andrade in 2011 and is headquartered in Cantanhede, Portugal. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Gilbert Wagener
| Erasmus University Rotterdam | Doctorate Degree |
| University of Basel | Masters Business Admin |
| Philipps University of Marburg | Doctorate Degree |
Statistik
International
| Niederlande | 2 |
| Schweiz | 2 |
| Deutschland | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 3 |
| Doctorate Degree | 2 |
| Masters Business Admin | 1 |
Sektoral
| Consumer Services | 4 |
| Health Technology | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PHARNEXT SCA | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Cell2B - Advanced Therapeutics SA
Cell2B - Advanced Therapeutics SA BiotechnologyHealth Technology Cell2B - Advanced Therapeutics SA engages in the development of stem cell therapies for immune and inflammatory diseases. Its pipeline consists of cord blood unit expansion and anti-rejection medications. The company was founded by Daniela Couto, David Braga Malta, Francisco dos Santos, and Pedro Andrade in 2011 and is headquartered in Cantanhede, Portugal. | Health Technology |
Ixaka Ltd.
Ixaka Ltd. BiotechnologyHealth Technology Ixaka Ltd. engages in the development of advanced cell-based therapeutics for the treatment of critical limb ischemia. The company was founded by Gaby Salem and Vicente Saez Gonzalez in 2015 and is headquartered in London, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Gilbert Wagener
- Erfahrung
